Determination of the particle size of the catiazine substance by laser difraction

Authors

  • O. I. Cherniaieva State Institution “V. Danilevsky Institute for Endocrine Pathology Problems of the National Academy of Medical Sciences of Ukraine”, Ukraine https://orcid.org/0000-0001-5325-3165
  • L. Ye. Nikishyna State Institution “V. Danilevsky Institute for Endocrine Pathology Problems of the National Academy of Medical Sciences of Ukraine”, Ukraine
  • S. V. Kravchenko State Institution “V. Danilevsky Institute for Endocrine Pathology Problems of the National Academy of Medical Sciences of Ukraine”, Ukraine
  • I. S. Gritsenko National University of Pharmacy of the Ministry of Health of Ukraine, Ukraine https://orcid.org/0000-0002-5985-3847

DOI:

https://doi.org/10.24959/nphj.21.67

Keywords:

cathiazine; substance; particle size distribution; laser diffraction

Abstract

Aim. To determine the particle size distribution of the new original substance cathiazine by laser diffraction.

Materials and methods. The substance cathiazine was synthesized on the basis of d,l-camphoric acid and 2-aminothiazoline at the Institute of Endocrine Pathology Problems. The sperm-modulating effect of the new compound was proven in experimental animals. Its low toxicity at rather high efficiency was also confirmed. Determination of the particle
size of the powder of the substance cathiazine was performed by laser diffraction. The study was conducted on three laboratory batches. Optical microscopy was used to compare and confirm the results.

Results and discussion. It was found that the average median particle size of the powder of the substance cathiazine was: for batch 1 – 38 μm, for batch 2 – 33 μm, for batch 3 – 53 μm. The maximum size for 80 % of particles of batch 1 was 115 μm, batch 2 – 90 μm, batch 3 – 125 μm. Microphotographs of three batches of the substance cathiazine obtained by optical microscopy were presented. This method also confirmed that the size of the registered particles did not exceed 200 μm. This was in good agreement with the previous studies, in which the recommended average particle size should not exceed 100 μm, and the mass fraction of larger fractions was proposed to be controlled.

Conclusions. The particle size values of the powder substance cathiazine for three laboratory batches have been obtained. It has been found that the particle size and their size distribution in all laboratory batches of the substance cathiazine do not differ significantly. The data obtained can be used to normalize particle sizes in technology when
developing drugs

Author Biographies

O. I. Cherniaieva, State Institution “V. Danilevsky Institute for Endocrine Pathology Problems of the National Academy of Medical Sciences of Ukraine”

postgraduate student of the Department of Analytical Chemistry and Analytical Toxicology; junior researcher of the Laboratory of Analytical and Physicochemical Research

L. Ye. Nikishyna , State Institution “V. Danilevsky Institute for Endocrine Pathology Problems of the National Academy of Medical Sciences of Ukraine”

Candidate of Chemistry (Ph.D.), senior researcher, head of the Laboratory of Analytical and Physicochemical Research

S. V. Kravchenko , State Institution “V. Danilevsky Institute for Endocrine Pathology Problems of the National Academy of Medical Sciences of Ukraine”

researcher of the Laboratory of Analytical and Physicochemical Research

I. S. Gritsenko , National University of Pharmacy of the Ministry of Health of Ukraine

Doctor of Chemistry (Dr. habil.), professor of the Department of Analytical Chemistry and Analytical Toxicology

References

Фармакопейные методы определения размера частиц. Метод лазерной дифракции света в контроле гетерогенности лекарственных средств / Е. В. Успенская и др. Health and Education Millennium. 2016. Т. 18, № 9. P. 112–114.

Дослідження розміру та форми частинок лізиноприлу дигідрату та допоміжних речовин з метою отримання оптимальних фармакотехнологічних властивостей маси для таблетування / О. О. Салій та ін. Український біофармацевтичний журнал. 2019. №. 4 (61). Р. 9–16. DOI: https://doi.org/10.24959/ubphj.19.242.

Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective Saturday / Zhigang Sun et al. American Pharmaceutical Review. 2010. URL: https://bit.ly/3m5TU0W.

ОФС.1.2.1.0008.15 Определение распределения частиц по размеру методом лазерной дифракции света. URL: https://pharmacopoeia.ru/ofs-1-2-1-0008-15-opredelenie-raspredeleniya-chastits-po-razmeru-metodom-lazernoj-difraktsii-sveta/.

2.9.31 Визначення розміру частинок методом лазерної дифракції / ДП «Український науковий фармакопейний центр якості лікарських засобів». Державна Фармакопея України : в 3 т. 2–е вид. Харків : ДП «Український науковий фармакопейний центр якості лікарських засобів», 2015. Т. 1. С. 458.

3 (4,5-дигідротіазол-2-іл) амід цис-1,2,2-триметилциклопентан-1,3-дикарбонової кислоти, що стимулює : пат. 38130 Україна. № u 2000063139 ; заявл. 01.06.00 ; опубл. 13.05.01, Бюл. № 4. С. 159.

Зависимость растворимости фенсукцинала от размера частиц / А. И. Гризодуб и др. Фармаком. 2008. № 1. С. 50–67.

Downloads

Published

2021-10-19

Issue

No. 2(102) (2021)

Section

Technology of Medicines

License

Copyright (c) 2021 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).